Udayavni Special
  • Home
  • Anti Malarial drug

New studies reveal HCQ, chloroquine do not show antiviral effect against COVID-19

WHO ends hydroxychloroquine trial for COVID-19

Scientists find no survival benefit of treating COVID-19 patients with HCQ

Lancet retracts study that linked HCQ to increased death risk

WHO approves trial of HCQ for potential COVID-19 treatment

WHO suspends COVID-19 trials of HCQ over safety issues

Hydroxychloroquine linked to increased risk of death in hospitalized Covid-19 patients: Study

Covid-19: West Bengal to ramp up the production of Hydroxychloroquine

India to export HCQ only to foreign govts and not to pvt companies: Sources

Lifesaving drugs should be made available to Indians first: Rahul Gandhi

India partially lifts ban on export of paracetamol and anti-malarial drug HCQ

Would be surprised if India doesn’t allow export of Hydroxychloroquine to US: Trump

Trump requests Modi to release Hydroxychloroquine ordered by US

Latest Additions

PM reviews projects worth Rs 44,545 crore in ‘Pragati’ meeting

Ghana is first nation in world to receive COVAX vaccines

Number of UHN Indians to rise 63 pc to 11,198 in 5 yrs says report

Right to silence is virtue in present noisy times: Facebook VP tells SC

K’taka COVID-19 update: 334 new cases, 313 discharges, 6 deaths on Feb 23

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.